TLR5 binding and activation by KMRC011, a flagellin-derived radiation countermeasure.

Entolimod (CBLB502) is a flagellin-derived radiation countermeasure currently under clinical trial. Entolimod exerts radioprotective activity by directly interacting with TLR5, an innate immune receptor, using the conserved domains of flagellin. Entolimod was designed to contain an artificially introduced N-terminal region that is not related to drug effects and might trigger unexpected toxic immunogenic reactions in humans. To refine the entolimod drug design, we engineered entolimod into KMRC011 by removing its ancillary region. The TLR5 binding and activating capacities of KMRC011 were assessed through biophysical and cellular analyses. KMRC011 forms an exceptionally stable complex with TLR5 at a 1:1 molar ratio with an equilibrium dissociation constant of ∼100 pM and potently activates TLR5. Moreover, alanine scanning mutagenesis identified the R90 and E114 residues of KMRC011 as a TLR5 activation hotspot. Further comparative analysis demonstrated that KMRC011 binds and activates TLR5 in a mode similar to that of entolimod. Thus, we propose that KMRC011 can be used in place of entolimod as a second-generation radiation countermeasure that shows none of the immunogenic side effects derived from the entolimod ancillary region.

• Publication year

  2019

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2019-01-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbrc.2018.11.080PMID 30509486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A conserved TLR5 binding and activation hot spot on flagellin

  2017cited by this paper
• Toll‐like receptor 5 signaling restrains T‐cell/natural killer T‐cell activation and protects against concanavalin A–induced hepatic injury

  2017cited by this paper
• A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures

  2017cited by this paper
• Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis

  2016cited by this paper
• Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA.

  2016cited by this paper
• Autoinhibition and relief mechanism by the proteolytic processing of Toll-like receptor 8

  2016cited by this paper
• The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates

  2015cited by this paper
• Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists

  2015cited by this paper
• Crystal structure of FliC flagellin from Pseudomonas aeruginosa and its implication in TLR5 binding and formation of the flagellar filament.

  2014cited by this paper
• Radiation countermeasure agents: an update (2011 – 2014)

  2014cited by this paper
• Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury.

  2012cited by this paper
• Structural Basis of TLR5-Flagellin Recognition and Signaling

  2012cited by this paper
• Single Molecule In Vivo Analysis of Toll-Like Receptor 9 and CpG DNA Interaction

  2011cited by this paper
• Radiation Injury After a Nuclear Detonation: Medical Consequences and the Need for Scarce Resources Allocation

  2011cited by this paper
• Acute Radiation Syndrome: Assessment and Management

  2010cited by this paper
• Pharmacological countermeasures for the acute radiation syndrome.

  2009cited by this paper
• Pharmacological Countermeasures for the Acute Radiation Syndrome

  2009cited by this paper
• An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models

  2008cited by this paper
• The TLR3 signaling complex forms by cooperative receptor dimerization

  2008cited by this paper
• Flagellin Treatment Protects against Chemicals, Bacteria, Viruses, and Radiation1

  2008cited by this paper
• Identification of Conserved Domains in Salmonella muenchen Flagellin That Are Essential for Its Ability to Activate TLR5 and to Induce an Inflammatory Response in Vitro*

  2004cited by this paper
• Complete atomic model of the bacterial flagellar filament by electron cryomicroscopy

  2003cited by this paper
• Modeller: generation and refinement of homology-based protein structure models.

  2003cited by this paper
• Lipopolysaccharide Interaction with Cell Surface Toll-like Receptor 4-MD-2

  2003cited by this paper
• Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility

  2003cited by this paper
• Structure of the bacterial flagellar protofilament and implications for a switch for supercoiling

  2001cited by this paper
• Refinement of macromolecular structures by the maximum-likelihood method.

  1997cited by this paper

• Balancing Regeneration and Resistance: Targeting DCLK1 to Mitigate Gastrointestinal Radiation Injury and Oncogenesis

  2025cites this paper
• Unraveling the complexity of radiotherapy- and chemotherapy-induced oral mucositis: insights into pathogenesis and intervention strategies

  2025cites this paper
• TLR5 agonist in combination with anti-PD-1 treatment enhances anti-tumor effect through M1/M2 macrophage polarization shift and CD8+ T cell priming

  2024cites this paper
• Focus on the Mechanisms and Functions of Pyroptosis, Inflammasomes, and Inflammatory Caspases in Infectious Diseases

  2022cites this paper
• Dimethyl Sulfoxide Attenuates Radiation-Induced Testicular Injury through Facilitating DNA Double-Strand Break Repair

  2022cites this paper
• Medical countermeasures for extraterrestrial environments : Current status and future prospects with focus on acute injuries

  2022cites this paper
• Clinical evaluation of toll-like receptor-5 agonist for radiation-induced oral mucositis in beagle dogs

  2022cites this paper
• Protective Role of the Toll-Like Receptor 5 Agonist KMRC011 against Murine Colitis Induced by Citrobacter rodentium and Dextran Sulfate Sodium

  2022cites this paper
• A first‐in‐human study of KMRC011, a potential treatment for acute radiation syndrome, to explore tolerability, pharmacokinetics, and pharmacodynamics

  2021cites this paper
• KMRC011, an agonist of toll-like receptor 5, mitigates irradiation-induced tissue damage and mortality in cynomolgus monkeys

  2020cites this paper
• Radioprotective effect of newly synthesized toll-like receptor 5 agonist, KMRC011, in mice exposed to total-body irradiation

  2019cites this paper
• ODU Digital Commons ODU Digital Commons

  year unknowncites this paper